WCM
ABBV icon

WealthTrak Capital Management’s AbbVie ABBV Stock Holding History

WealthTrak Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-328
Closed -$60.9K – 80
2025
Q2 		$60.9K Buy
328
+24
+8% +$4.46K 0.05% 100
2025
Q1 		$63.7K Buy
304
+64
+27% +$12.4K 0.05% 92
2024
Q4 		$42.6K Buy
+240
New +$44.1K 0.04% 106

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WealthTrak Capital Management's ABBV Position: Q3 2025 in Review

WealthTrak Capital Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 328 shares — an estimated $60.9K sold.

WealthTrak Capital Management first reported a position in ABBV in Q4 2024 and held it in 3 quarters. The position peaked at $63.7K in Q1 2025. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • WealthTrak Capital Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • WealthTrak Capital Management sold 328 AbbVie shares in Q3 2025, an estimated $60.9K.
  • WealthTrak Capital Management first reported a position in AbbVie in Q4 2024 and held it in 3 quarters.
  • WealthTrak Capital Management's AbbVie position peaked at $63.7K in Q1 2025.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on WealthTrak Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.